Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Pfizer Ltd
Femme et Homme Max 99 ans
Pfizer Ltd. Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
MAJ Il y a 5 ans
A two-year multi-centre, randomized two arm study of Genotropin treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN)
The primary objective of this trial is to evaluate the efficacy of Genotropin® treatment on height velocity SDS in short SGA children starting treatment at an age of 24-30 months as compared to untrea...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
A randomised, double-blind, parallel group trial to assess the variability and treatment effect size for a Neuropathic Pain offset design
To estimate the difference in average daily pain score (ADPS) after 4 weeks in patients maintained on the ‘standard’ dose of gabapentin compared to those on a reduced dose of gabapentin. To estimate t...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd. Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
MAJ Il y a 5 ans
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE EFFICACY AND SAFETY OF CP-945,598 IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS
To evaluate the efficacy of 20 mg QD and 5 mg QD of CP-945,598 given for 48 weeks in the treatment of NASH.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly healthy volunteers
To investigate the safety and toleration of multiple oral doses of (+)-[S,S]-RBX administeredonce daily in an extended release formulation in young and elderly volunteers. To investigate the steady ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Pfizer Ltd (UK)
MAJ Il y a 5 ans
A placebo controlled, flexible dose, randomised controlled trial to assess the efficacy of sildenafil citrate in men with erectile dysfunction after anterior resection for rectal carcinoma
Not provided at time of registration
Pays
United Kingdom
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
A phase II, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of UK-500,001 Dry Powder for Inhalation (DPI) in adults with moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
To evaluate the efficacy and safety/tolerability of UK-500,001 DPI in adults with moderate to severe COPD (Global initiative in Obstructive Lung Disease [GOLD] stage II/III).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
A PHASE IIb RANDOMISED DOUBLE BLIND, PLACEBO CONTROLLED PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-00610355 OVER 4 WEEKS IN MODERATE ASTHMATIC SUBJECTS
To assess the efficacy of PF-00610355 (‘once daily’ QD doses of 100 mcg, 300 mcg and 600 mcg) in the treatment of moderate asthma following 4 weeks treatment.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
An open-label, multi-center trial of azithromycin pharmacokinetics in sinus aspirate and serum following oral administration of either a 500 mg immediate-release (IR) once-daily 3 day regimen or a single-dose 2.0g azithromycin microspheres regimen in subjects with acute bacterial sinusitis
Main objective :To characterize the pharmacokinetics of azithromycin in maxillary sinus aspirate and in serum in adult subjects with acute bacterial sinusitis after treatment with azithromycin IR 500 ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
AN OPEN-LABEL, MULTICENTER STUDY WITH FOLLOW-UP EVALUATING THE SAFETY AND EFFICACY OF VARENICLINE TARTRATE IN COMPARISON TO TRANSDERMAL NICOTINE PATCH FOR SMOKING CESSATION
Compare Varenicline to NRT for smoking cessation efficacy at the end of 12 weeks of varenicline treatment and 10 weeks of NRT treatment, using the 4-week Continuous Quit Rate (CQR) as the primary meas...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Ltd
MAJ Il y a 5 ans
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF RESPONSE IN PATIENTS WITH ACUTE MANIA
The aim of this study is to compare the efficacy and tolerability of ziprasidone versus olanzapine in the treatment of acute mania.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
Suivant